Home > Insider Trading > Filing (0000904454-18-000522)

Filing Details

Accession Number:: 0000904454-18-000522
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-08-27 17:03:03
Reporting Period:: 2018-08-23

Accepted Time:: 2018-08-27 17:03:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1411690	Bionano Genomics Inc	BNGO	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1013425	I Jesse Treu	C/O Domain Associates, Llc One Palmer Square Princeton NJ 08542	No	No	Yes	No
1024000	C James Blair	C/O Domain Associates, Llc One Palmer Square Princeton NJ 08542	No	No	Yes	No
1196863	Nicole Vitullo	C/O Domain Associates, Llc One Palmer Square Princeton NJ 08542	No	No	Yes	No
1207786	H Brian Dovey	C/O Domain Associates, Llc One Palmer Square Princeton NJ 08542	No	No	Yes	No
1354718	K Brian Halak	C/O Domain Associates, Llc One Palmer Square Princeton NJ 08542	No	No	Yes	No
1465144	Domain Partners Viii, L.p.	C/O Domain Associates, Llc One Palmer Square Princeton NJ 08542	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-08-23	591,184	$0.00	591,184	No	4	C	Direct
Common Stock	Acquisiton	2018-08-23	337,694	$4.59	929,878	No	4	C	Direct
Common Stock	Acquisiton	2018-08-23	15,000	$6.13	943,878	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Preferred Stock	Disposition	2018-08-23	6,810,098	$0.00	159,115	$0.00
Common Stock	Series B-1 Preferred Stock	Disposition	2018-08-23	2,986,762	$0.00	69,784	$0.00
Common Stock	Series C Preferred Stock	Disposition	2018-08-23	5,426,808	$0.00	126,794	$0.00
Common Stock	Series D Preferred Stock	Disposition	2018-08-23	6,396,105	$0.00	149,441	$0.00
Common Stock	Series D-1 Preferred Stock	Disposition	2018-08-23	3,682,919	$0.00	86,050	$0.00
Common Stock	Convertible Promissory Note	Disposition	2018-08-23	0	$0.00	337,694	$4.59
Common Stock	Warrants to Purchase Common Stock	Acquisiton	2018-08-23	15,000	$0.00	15,000	$6.13

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct
0			No	4	C	Direct
0			No	4	C	Direct
0			No	4	C	Direct
0			No	4	C	Direct
0			No	4	C	Direct
15,000	2018-09-20	2023-09-20	No	4	P	Direct

Footnotes

All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The Preferred Stock had no expiration date
The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.
The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $1,488,952. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the "Conversion Amount") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 75% of the IPO price per share of $6.125 per share.
The Common Stock and Warrants to Purchase Common Stock were issued and sold as units at a purchase price of $6.125 per unit. Each unit consists of one share of Common Stock and one Warrant to purchase one share of Common Stock. The units will separate, and the underlying Common Stock and Warrants will begin trading separately, no later than 30 days following the date of the IPO prospectus, at which time the Warrants will become exercisable for a period of five years.